Literature DB >> 2030724

Acquired abnormalities of platelet function.

.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 2030724      PMCID: PMC7886021          DOI: 10.1056/NEJM199106063242313

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Platelet aggregation in portal cirrhosis.

Authors:  H S Ballard; A J Marcus
Journal:  Arch Intern Med       Date:  1976-03

2.  Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time.

Authors:  P M Mannucci; V Vicente; L Vianello; M Cattaneo; I Alberca; M P Coccato; E Faioni; D Mari
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

3.  A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver.

Authors:  A Ordinas; S Maragall; R Castillo; A T Nurden
Journal:  Thromb Res       Date:  1978-08       Impact factor: 3.944

4.  Use of DDAVP in inherited and acquired platelet dysfunction.

Authors:  D M DiMichele; W E Hathaway
Journal:  Am J Hematol       Date:  1990-01       Impact factor: 10.047

5.  Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

Authors:  P M Mannucci; G Remuzzi; F Pusineri; R Lombardi; C Valsecchi; G Mecca; T S Zimmerman
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

6.  Desmopressin and bleeding time in patients with cirrhosis.

Authors:  A K Burroughs; K Matthews; M Qadiri; N Thomas; P Kernoff; E Tuddenham; N McIntyre
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16
  6 in total
  1 in total

1.  Suspected intraoperative formation of left atrial thrombus in a patient with atrial fibrillation receiving bridging anticoagulation therapy.

Authors:  Kohei Godai; Maiko Hasegawa-Moriyama; Kana Unoki; Yoji Uchida; Tamotsu Kuniyoshi; Akira Matsunaga; Yuichi Kanmura
Journal:  J Anesth       Date:  2013-06-28       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.